Optimise viewing for

Toggle between patient and health professional views. The patient version is simplified to help people easily find suitable trials, while the professional view provides full detail.

Health ProfessionalsPatients

RecruitingLast updated: 14 August 2025

The purpose of this study is to provide venetoclax and obtain long-term safety data for people who have participated in a previous venetoclax clinical trial and continue to derive benefit from itAn Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Trial purpose

Medical clipboardCancer treatment

Tumor type

Blood Cancers Haematological

Clinical summary

Summary

Participants will receive venetoclax, as an oral tablet, at the same dose they received during the previous venetoclax clinical trial in which they were enrolled.

Conditions

This trial is treating people with chronic lymphocytic leukaemia, acute myeloid leukaemia, multiple myeloma, non-Hodgkin's lymphoma, or acute lymphoblastic leukaemia who have participated in a previous venetoclax clinical trial

Eligibility

Inclusion

  • Subject has been enrolled and dosed in an ongoing venetoclax study and continues to tolerate and derive benefit from the study drug.
  • Male subject agrees to refrain from sperm donation.
  • Female subjects must not be pregnant or breastfeeding.

Exclusion

- None.

Inclusion

  • You have previously participated in a certain specific clinical trial.
  • You have had a certain type of treatment or surgical procedure.
Message

Clinical trials have complex eligibility criteria, and other criteria may apply for this trial. Ask your doctor about whether this trial could be right for you.

Participating hospitals

Recruiting hospitals

InformationTell us if you find this trial availability is not accurate.Report inaccuracy

More information

Trial Identifiers

Information on this page is partially produced from ClinicalTrials.gov *. View further details about this trial on the registry via the links below:

Trial sponsor

AbbVie

Scientific Title

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Get Support

Peer Connect

You might find it helpful to speak to someone who has 'been there before'. Our Peer Connect program can provide one-on-one phone support from someone who understands what you're going through and has clinical trials experience.

Know more about Peer Connect

Contact cancer support

If you need cancer information and practical support for yourself, a carer, family or friend, contact Cancer Council to speak with an experienced health professional on 13 11 20.

Get support

Multilingual information

Learn more about clinical trials through this collection of resources in languages other than English.

View information

CloseReport inaccuracy

Thank you for helping us to increase accuracy of the trial. Our team will validate the information and update the information as soon as possible.

HelpThis verification step helps prevent fraudulent transactions from automated software.
Submitting ... Please wait